Apex Science & Engineering Corp. (TPE:3052)
Taiwan · Delayed Price · Currency is TWD 10.45
0.00 (0.00%)
May 29, 2026, 1:30 PM CST
TPE:3052 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,523 | 3,420 | 2,660 | 3,484 | 2,952 | 3,615 | |
Revenue Growth (YoY) | 29.03% | 28.59% | -23.66% | 18.04% | -18.34% | -30.72% |
Cost of Revenue | 3,130 | 2,990 | 2,299 | 3,096 | 2,584 | 3,410 |
Gross Profit | 392.78 | 430.19 | 361 | 387.92 | 367.21 | 204.91 |
Selling, General & Admin | 164.78 | 164.83 | 168.1 | 164.21 | 155.75 | 135.02 |
Research & Development | 1.74 | 1.8 | 2.3 | 2.03 | 2.75 | 1.83 |
Operating Expenses | 167.29 | 167.4 | 170.4 | 166.24 | 160.19 | 136.95 |
Operating Income | 225.48 | 262.79 | 190.6 | 221.68 | 207.03 | 67.96 |
Interest Expense | -32.75 | -32.1 | -32.96 | -22.47 | -16.14 | -21.66 |
Interest & Investment Income | 31.77 | 37.03 | 62.85 | 41.73 | 33.38 | 61.33 |
Earnings From Equity Investments | - | - | 7.75 | 25.41 | 31.34 | 30.88 |
Currency Exchange Gain (Loss) | -1.34 | -1.34 | 7.49 | -0.58 | 11.45 | -0.53 |
Other Non Operating Income (Expenses) | 16.69 | 12.45 | 3.29 | 7.46 | 8.27 | 1.34 |
EBT Excluding Unusual Items | 239.86 | 278.82 | 239.02 | 273.24 | 275.32 | 139.32 |
Gain (Loss) on Sale of Investments | - | - | -13.23 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 28 | 0.01 | 0.21 | -0.17 |
Other Unusual Items | - | - | - | 0.01 | - | - |
Pretax Income | 239.86 | 278.82 | 253.8 | 273.25 | 275.52 | 139.15 |
Income Tax Expense | 45.31 | 52.86 | 50.86 | 66.07 | 67.11 | 33.14 |
Earnings From Continuing Operations | 194.55 | 225.96 | 202.94 | 207.18 | 208.41 | 106.01 |
Minority Interest in Earnings | -1.48 | -1.77 | -3.22 | -2.38 | -1.48 | -3.27 |
Net Income | 193.07 | 224.19 | 199.73 | 204.79 | 206.93 | 102.74 |
Net Income to Common | 193.07 | 224.19 | 199.73 | 204.79 | 206.93 | 102.74 |
Net Income Growth | -9.83% | 12.25% | -2.47% | -1.03% | 101.41% | -67.45% |
Shares Outstanding (Basic) | 204 | 204 | 204 | 204 | 205 | 206 |
Shares Outstanding (Diluted) | 204 | 206 | 206 | 206 | 208 | 208 |
Shares Change (YoY) | -1.11% | 0.04% | -0.05% | -0.70% | 0.08% | -0.89% |
EPS (Basic) | 0.95 | 1.10 | 0.98 | 1.00 | 1.01 | 0.50 |
EPS (Diluted) | 0.95 | 1.09 | 0.97 | 0.99 | 1.00 | 0.49 |
EPS Growth | -8.98% | 12.37% | -2.02% | -1.00% | 104.00% | -67.52% |
Free Cash Flow | 1,839 | 1,794 | 373.22 | 1,233 | 396.76 | 543.21 |
Free Cash Flow Per Share | 9.02 | 8.70 | 1.81 | 5.97 | 1.91 | 2.62 |
Dividend Per Share | 0.600 | 0.600 | 0.500 | 0.392 | 0.385 | 0.240 |
Dividend Growth | 20.00% | 20.00% | 27.49% | 2.00% | 60.01% | -68.75% |
Gross Margin | 11.15% | 12.58% | 13.57% | 11.13% | 12.44% | 5.67% |
Operating Margin | 6.40% | 7.68% | 7.17% | 6.36% | 7.01% | 1.88% |
Profit Margin | 5.48% | 6.55% | 7.51% | 5.88% | 7.01% | 2.84% |
Free Cash Flow Margin | 52.20% | 52.47% | 14.03% | 35.38% | 13.44% | 15.03% |
EBITDA | 233.1 | 270.25 | 196.84 | 227.41 | 212.41 | 73.01 |
EBITDA Margin | 6.62% | 7.90% | 7.40% | 6.53% | 7.20% | 2.02% |
D&A For EBITDA | 7.61 | 7.46 | 6.23 | 5.73 | 5.38 | 5.05 |
EBIT | 225.48 | 262.79 | 190.6 | 221.68 | 207.03 | 67.96 |
EBIT Margin | 6.40% | 7.68% | 7.17% | 6.36% | 7.01% | 1.88% |
Effective Tax Rate | 18.89% | 18.96% | 20.04% | 24.18% | 24.36% | 23.82% |